Shineway's performance growth would be under pressure in 23H2 and 24H1.It's uncertain whether 24H2 would see some rebound considering TCM formula granules VBP.Dividends next year is looking forward to
Boomeranged on Thu, 21 Mar 2024 09:26
Recent rally of Shineway's share price is mainly due to mproved liquidity after included in Hong Kong Stock Connect this March. 2023 Positive profit alert is also one reason. There's currently some noise - Positive policy on TCM injections in NRDL reimbursement would help drive up future growth, but VBP on TCM formula granules is headwind. We'll wait to see the 2023 report to reassess the outlook.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.